Its sister drugs, Wegovy and Rybelsus, are also semiglutide drugs that are FDA-approved for weight loss
For example, if someone on tirzepatide experiences dizziness, it could be due to: Low blood sugar from other diabetes medications Dehydration from vomiting or diarrhea A separate health issue like anemia or heart problems Still, when similar reports appear over and over, they raise a red flag
Your journey to a healthier you is just a click away
The American Diabetes Association (ADA) 2024 Standards of Care support GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists, including tirzepatide, particularly in patients with: Established atherosclerotic cardiovascular disease or high cardiovascular risk Chronic kidney disease Need for substantial A1c reduction (tirzepatide typically reduces A1c by 1.5-2.5%) Desire to avoid weight gain or achieve weight loss Inadequate glycemic control on metformin or other oral agents Tirzepatide is not approved for type 1 diabetes or diabetic ketoacidosis
Several aspects remained undetermined in this study
"This substance is not approved for sale or use as a tanning agent in Australia and has not been assessed for safety or quality," it said
